Improved results after preoperative concurrent chemotherapy and high dose radiation therapy in selected cases with stage III N2 lung cancer? Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Complete endosonographic nodal staging of lung cancer in patients eligible for stereotactic ablative radiotherapy (STAGE study NCT02997449) Source: International Congress 2017 – Interventional pulmonology highlights 2017 Year: 2017
Is EBUS sampling adequate for molecular testing in patients with advanced NSCLC? Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020
Survival and recurrences following surgical treatment of N2 NSCLC Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006
Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003
The efficacy of induction chemoradiotherapy followed by surgery in stage IIIA-proven N2 NSCLC and the influence of lymph node downstage on the incidence of postoperative recurrence Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Indcution chemotherapy and radiotherapy vs. induction and simultaneous radiochemotherapy in inoperable stage III NSCLC. Update on BROCAT study CTRT 99/97 Source: Eur Respir J 2006; 28: Suppl. 50, 833s Year: 2006
Factors predicting complete surgical resection after induction chemotherapy in patients with initially unresectable non-small cell lung cancer (NSCLC) treated in a randomised trial Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003
A new two-step algorithm for the treatment of COPD Source: Eur Respir J , 49 (2) 1602200; DOI: 10.1183/13993003.02200-2016 Year: 2017
Chemotherapy plus resection is not better than chemoradiotherapy for baseline unresectable stage IIIA-N2 NSCLC Source: ISSN=ISSN 1810-6838, ISBN=, page=380 Year: 2007
Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018
Mode of early relapse in resectable I-IIIA NSCLC – prospective, controlled study Source: Eur Respir J 2005; 26: Suppl. 49, 168s Year: 2005